Metastatic Ovary Cancer

2

Review clinical trials related to Metastatic Ovary Cancer. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

A Phase I Study to Evaluate the Safety,Pharmacokinetics,Pharmacodynamics,and Efficacy of TJ037130 in Adult Participants With Advanced Solid Tumors

The goal of this clinical trial is to evaluate the safety and tolerability of TJ037130 in participants with advanced or metastatic solid tumors, and to determine the Potential Optimal Biological Dose (POBD) of TJ037130 for subsequent investigations.

Participants needed: 128
Trial details
Phase: Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: TJ Biopharma Co., Ltd.Updated: Jul 20, 2026Locations: 1
Eligibility criteria

Males or females aged 18 years or older; [+9]

Prior exposure to CLDN6-targeted therapy; [+3]

Status: Recruiting

Measuring Oncological Value of Exercise and Statin

The aim of the study is to find out whether supervised physical exercise during cancer drug treatment improves the effectiveness of the treatment in metastasized breast, kidney, ovarian and prostate cancer compared to unsupervised exercise. In addition, the investigators are investigating whether the use of atorvastatin combined with guided group exercise training would further improve the response to cancer treatment.

Participants needed: 240
Trial details
Phase: Phase 3Age: 18-99Biological sex: AllType: InterventionalSponsor: Tampere University HospitalUpdated: Jun 27, 2025Locations: 1
Eligibility criteria

The patient has metastatic prostate cancer, breast cancer, ovarian cancer or kid... [+7]

High risk of bone fractures [+12]